Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
CC transcript
Appointed director
Asset disposition
Quarterly results
Director departure
|
|
ASENSUS SURGICAL, INC. (TRXC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
8-K
| Quarterly results |
| 05/15/2023 |
8-K
| Quarterly results |
| 03/02/2023 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 08/11/2022 |
8-K
| Quarterly results |
| 05/05/2022 |
8-K
| Quarterly results |
| 11/04/2021 |
8-K
| Quarterly results |
| 08/06/2021 |
8-K
| Quarterly results |
| 11/09/2020 |
8-K
| Quarterly results |
| 08/07/2020 |
8-K
| Quarterly results |
| 05/19/2020 |
8-K
| Quarterly results|
Docs:
|
"TransEnterix, Inc. Reports Operating and Financial Results for the First Quarter 2020 May 14, 2020, at 6:55 AM EST",
"PRESENTATION Operator Good afternoon, and welcome to the TransEnterix First Quarter 2020 Business Update Conference Call. As a reminder, today's call is being webcast live and recorded. After the speaker presentation there will be a question and answer session. Please be advised that today's conference may be recorded.I would now like to introduce your host, Mr. Mark Klausner of Westwicke. Please go ahead, sir. Mark R. Klausner Westwicke Partners, LLC - Managing Partner Thanks, operator. Good morning, everyone, and thank you for joining us on today's call. On the call with me today are Anthony Fernando, President and Chief Executive Officer; and Brett Farabaugh, Interim Chief Financial Officer. Before we begin, I would like to caution listeners that certain information discussed by managem..." |
|
| 11/13/2019 |
8-K
| Quarterly results |
| 08/08/2019 |
8-K
| Quarterly results |
| 05/10/2019 |
8-K
| Quarterly results |
| 11/13/2018 |
8-K
| Quarterly results |
| 08/09/2018 |
8-K
| Quarterly results|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 August 7, 2018 Date of Report TransEnterix, Inc. Delaware 0-19437 11-2962080 635 Davis Drive, Suite 300 Morrisville, North Carolina 919-765-8400 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 u...",
"TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2018 RESEARCH TRIANGLE PARK, N.C.——TransEnterix, Inc. , a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the second quarter 2018. Recent Highlights",
"August 7, 2018 conference call script" |
|
| 05/10/2018 |
8-K
| Quarterly results |
| 11/13/2017 |
8-K
| Quarterly results |
| 08/04/2017 |
8-K
| Quarterly results |
| 05/12/2017 |
8-K
| Quarterly results |
| 11/14/2016 |
8-K
| Form 8-K - Current report |
| 08/09/2016 |
8-K
| Quarterly results |
| 05/13/2016 |
8-K
| Form 8-K - Current report |
| 11/09/2015 |
8-K
| Quarterly results |
| 08/06/2015 |
8-K
| Quarterly results|
Docs:
|
"TransEnterix, Inc. Reports Operating Results for the Second Quarter 2015 RESEARCH TRIANGLE PARK, N.C., — — TransEnterix, Inc. , a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the second quarter 2015. Operating Highlights • Completed Good Laboratory Practices Studies using the SurgiBot™ System in April 2015 • SurgiBot System FDA 510 Application Submitted June 1, 2015 • Completed underwritten equity offering raising $52.2 million in net proceeds, including the underwriters exercise of additional shares in July 2015 “We are pleased to have submitted our 510 application to the FDA for the SurgiBot System,” said Todd M. Pope, President and Chief Executive Offi..." |
|
| 05/08/2015 |
8-K
| Quarterly results|
Docs:
|
"TransEnterix, Inc. Reports Operating Results for the First Quarter 2015 RESEARCH TRIANGLE PARK, N.C., — — TransEnterix, Inc. , a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the first quarter 2015. Operating Highlights • Announces Completion of GLP Studies • SurgiBot system FDA 510 Submission Expected in June 2015 “We are pleased with our progress in the first quarter and to have successfully completed our GLP studies, a key remaining step prior to our 510 submission,” said Todd M. Pope, President and Chief Executive Officer of TransEnterix. “We are pleased to announce that we now anticipate being in a position to make our 510 submission for the SurgiBot ...",
"May 6, 2015 Conference Call Script" |
|
| 02/26/2015 |
8-K
| Quarterly results |
| 11/12/2014 |
8-K
| Quarterly results|
Docs:
|
"TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2014 RESEARCH TRIANGLE PARK, N.C., — — TransEnterix, Inc. , a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the third quarter 2014. Operating Results • In August 2014, Dr. Helmuth Billy performed a successful sleeve gastrectomy surgery using TransEnterix's Flex Ligating Shears, which was broadcast at the 5th International Conference on Sleeve Gastrectomy. TransEnterix's Flex Ligating Shears are the only fully flexible advanced energy device available that offers ligation and division of tissue with direct thermal fusion. • In September 2014, the Company expanded its existing l...",
"Conference Call Transcript" |
|
| 08/11/2014 |
8-K
| Quarterly results |
| 05/09/2014 |
8-K
| Quarterly results |
| 11/18/2013 |
8-K
| Quarterly results |
| 11/16/2004 |
8-K
| Form 8-K - Current report |
|
|